SOTYKTU 6 mg film coated tablets

Manufacturer
PATHEON INC.(CANADA)

Registraction Number
MAL24086002ACRZ

Content:
SOTYKTU 6 mg Film-Coated Tablets contain 6 mg of deucravacitinib as the active ingredient. Deucravacitinib is a tyrosine kinase 2 (TYK2) inhibitor used to treat moderate to severe plaque psoriasis.
Indications:
SOTYKTU is used to treat:

• Moderate to Severe Plaque Psoriasis: An inflammatory skin condition that causes red, scaly, thick, itchy, and painful patches on the skin, scalp, nails, hands, and feet.

• Dosage: The recommended dose is 6 mg taken orally once daily, with or without food.
• Administration: Take the tablet with water.
• Consistency: Take the medication at the same time each day to help you remember.
• Precautions: Inform your doctor if you have any history of infections, tuberculosis, heart problems, or cancer. Avoid use in combination with other potent immunosuppressants.